Effect of intraincisional bupivacaine infusion in intertrochanteric fracture

Phase 2

Recruiting

Conditions: Femur fracture.
S72.14
Intertrochanteric fracture of femur

Registration Number: IRCT20100127003213N8

Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 48

Inclusion Criteria

Patients who scheduled to undergo hip nailing surgery and can tolerate surgery under spinal anesthesia
American Society of Anesthesiologists (ASA) I-II
50-85 years of age

Exclusion Criteria

Uncontrolled seizure
Local infection
Coagulopathy
Thrombocytopenia
History of hepatic and renal function impairment
narcotic addiction
Allergy to drugs which are going to be used in this study
History of Psychosomatic pain
Psychiatric diseases
Diabetic neuropathy
2nd and 3rd degree A-V block

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain intensity. Timepoint: Every 15 minutes after surgery (15, 30, 45, 60 minutes) in recovery room, and every 2 hours after transfer to ward . Method of measurement: Numerical Rating Scale of pain.;Total morphine administration. Timepoint: total dose during the first postoperative 24 hours. Method of measurement: dose summation reported in milligrams.

Secondary Outcome Measures

Name	Time	Method
Patient’s global satisfaction. Timepoint: Discharge from the ward. Method of measurement: ?A 5-point Likert scale: completely satisfied (= 5), partially satisfied (= 4), neutral (= 3), partially dissatisfied (= 2) and completely dissatisfied (= 1).;Ease of ambulation. Timepoint: During admission. Method of measurement: Cumulated Ambulation Score.;Time to first request for analgesia. Timepoint: Time to first request, measured from termination of the procedure and recovery room entry. Method of measurement: minute.;Drug side effects (nausea & vomiting, respiratory depression, urinary retention, drowsiness, pruritus, hypotension, tinnitus). Timepoint: Every four hours for 24 hours. Method of measurement: Occurrence frequency.